Cargando…
Peptides Targeting the Interaction Between Erb1 and Ytm1 Ribosome Assembly Factors
Ribosome biogenesis is an emerging therapeutic target. It has been proposed that cancer cells are addicted to ribosome production which is therefore considered a druggable pathway in cancer therapy. Cancer cells have been shown to be more sensitive to inhibition of the ribosome production than healt...
Autores principales: | Orea-Ordóñez, Lidia, Masiá, Susana, Bravo, Jerónimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440923/ https://www.ncbi.nlm.nih.gov/pubmed/34540895 http://dx.doi.org/10.3389/fmolb.2021.718941 |
Ejemplares similares
-
Concerted removal of the Erb1–Ytm1 complex in ribosome biogenesis relies on an elaborate interface
por: Thoms, Matthias, et al.
Publicado: (2016) -
The structure of Erb1-Ytm1 complex reveals the functional importance of a high-affinity binding between two β-propellers during the assembly of large ribosomal subunits in eukaryotes
por: Wegrecki, Marcin, et al.
Publicado: (2015) -
The Mechanisms of Action of Ribosome-Targeting Peptide Antibiotics
por: Polikanov, Yury S., et al.
Publicado: (2018) -
GTPase Era at the heart of ribosome assembly
por: Gruffaz, Christelle, et al.
Publicado: (2023) -
Exploring Amyloidogenicity of Peptides From Ribosomal S1 Protein to Develop Novel AMPs
por: Galzitskaya, Oxana V.
Publicado: (2021)